Chinese scientists achieve diabetes cure through innovative cell therapy, detailed in Cell Discovery. Patient, treated in July 2021, no longer requires insulin after eleven weeks, and is now medication-free for 33 months. The breakthrough, praised by Timothy Kieffer, signifies a major advancement in diabetes treatment. This novel approach utilizes the body's regenerative abilities and could alleviate China's healthcare burden. Further studies are needed for validation.
If this were true you wouldn’t hear from this at all.
A permanent cure isn’t something that is wanted by pharma companies. It’s better for them to have something that keeps patients alive and that they need regularly and that is expensive but cheap enough for them to get.
But why wouldn’t a rival company just start up and sell the cures? Not all pharma companies sell insulin.
The bar to entry in the pharma market is extremely high. You need a lot of capital to enter it, which quickly disqualifies 95% of the population.
Now of course, people without money can still get funding from investors. But those investors are already racking big profits from the continuous model of insulin treatments. A cure would be a detriment to their profits, so it’s not something they’re interested in funding. Not all pharma is insulin, but it’s one of the bigger pharma industries.
This isn’t to mention that if you were one of the 5% and managed to have the resources to find and produce a cure, that the other mega corporations (with more funds than most of those 5% individuals) wouldn’t engage in anti competitive practices to shut you down. Many companies had good products but still ultimately failed.
Unfortunately capitalism does not allow innovation to flourish like many of us were taught to believe.
Because then the rival company would also go out of business. The pharma industry is not about absolute cure but about continuously selling things - like all industries do. Medicine that cures you entirely and is not needed afterwards forever again is nothing the pharma industry wants.
Pharma wants that sweet IaaS platform. Insulin-as-a-service.
Eli Lilly and Company wants to know your location.